ACTSI Investigator Dr. Rafi Ahmed in the News

Rafi Ahmed, PhD, ACTSI investigator, director, Emory Vaccine Center, and professor, Department of Microbiology and Immunology, Emory University

Emory News Center | NIH awards Emory $35.6 million grant for research aimed at HIV/AIDS vaccine and cure
June 7, 2016

Atlanta Business Chronicle | Where will we be tomorrow without research today? 
January 8, 2016

Lab Land | Progress on universal flu vaccine
August 28, 2015

Emory News Center | Emory-India research partnership receives NIH award to study dengue virus infection
May 18, 2015

Emory News Center | Emory joins DARPA-funded Ebola research team led by Inovio Pharmaceuticals
April 16, 2015

The Scientist | Studying Ebola survivors
April 6, 2015

Nature | Ebola survivors offer clues to body's virus defenses
March 10, 2015

Emory News Center | First look at hospitalized Ebola survivors’ immune cells could guide vaccine design
March 9, 2015

International Business Times | The Hans India |  | Swine flu outbreak in India: Expert suggests new strains behind deaths, calls for virus studies
February 26, 2015

The Hindu | Sequence H1N1 virus in India: expert
February 24, 2015

Emory News Center | Immune ‘traffic jam’ from viral infection interferes with therapeutic antibodies
February 11, 2015

Health Sciences Update | Old drugs, news uses
February 5, 2015

Reuters | Fox News | Blood from Ebola survivors could help spur new disease treatments
February 4, 2015

Lab Land | General-heavy army disastrous in immune battle
January 20, 2015

Lab Land | Connections between starvation and immunological memory
December 18, 2014

Emory News Center | Institute of Medicine elects Emory transplant, vaccine leaders
October 20, 2014

Lab Land | Key to universal flu vaccine: embrace the unfamiliar
August 27, 2014

Atlanta Journal-Constitution | Recruit top science, research talent
July 1, 2014

Emory Medicine | Navigating a Complex Maze
Winter 2013

Health Sciences Update | New anti-cancer drugs are rooted in Emory research
November 22, 2013

Lab Land | Unexpected effect on flu immunity
November 5, 2013

Lab Land | Penetrating cancer’s shield
October 17, 2013

Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures
Immunity, December 15, 2015

Ahmed received the 2015 American Association of Immunologists Excellence in Mentoring Award. Ahmed has mentored more than 70 trainees in his career.

Thomson Reuters released "Highly Cited Researchers 2014" that identifies more than 3,000 researchers worldwide who wrote the greatest numbers of highly cited papers over the past decade. These researchers, including Ahmed, ranked in the top 1% most cited for their subject field and year of publication, "earning them the mark of exceptional impact," says the site.

The 2014 1% Club recognizes faculty, including Ahmed, whose NIH proposals have been ranked in the top 1% by NIH reviewers. Read More  

Game Changers: Reviving the Immune System
Keytruda (pembrolizumab), a melanoma drug, is based on inhibiting the PD-1 protein. In defining how PD-1 functions, Emory Vaccine Center director Rafi Ahmed and colleagues helped lay the groundwork for development of this drug, which received "breakthrough" status and accelerated approval from the FDA in 2013. Read more.